Bhattacharjee Rana, Thukral Anubhav, Chakraborty Partha Pratim, Roy Ajitesh, Goswami Soumik, Ghosh Sujoy, Mukhopadhyay Pradip, Mukhopadhyay Satinath, Chowdhury Subhankar
Department of Endocrinology and Metabolism, IPGME and R and SSKM Hospital, Kolkata, West Bengal, India.
Indian J Endocrinol Metab. 2017 Jan-Feb;21(1):26-30. doi: 10.4103/2230-8210.196017.
Glycated hemoglobin (HbA1c) can be altered in different conditions. We hypothesize that HbA1c levels may change due to altered thyroid status, possibly due to changes in red blood cell (RBC) turnover.
The objective of this study was to determine the effects of altered thyroid status on HbA1c levels in individuals without diabetes, with overt hyper- and hypo-thyroidism, and if present, whether such changes in HbA1c are reversed after achieving euthyroid state.
Euglycemic individuals with overt hypo- or hyper-thyroidism were selected. Age- and sex-matched controls were recruited. Baseline HbA1c and reticulocyte counts (for estimation of RBC turnover) were estimated in all the patients and compared. Thereafter, stable euthyroidism was achieved in a randomly selected subgroup and HbA1c and reticulocyte count was reassessed. HbA1c values and reticulocyte counts were compared with baseline in both the groups.
Hb A1c in patients initially selected was found to be significantly higher in hypothyroid group. HbA1c values in hyperthyroid patients were not significantly different from controls. HbA1c reduction and rise in reticulocyte count were significant in hypothyroid group following treatment without significant change in glucose level. Hb A1c did not change significantly following treatment in hyperthyroid group. The reticulocyte count, however, decreased significantly.
Baseline HbA1c levels were found to be significantly higher in hypothyroid patients, which reduced significantly after achievement of euthyroidism without any change in glucose levels. Significant baseline or posttreatment change was not observed in hyperthyroid patients. Our study suggests that we should be cautious while interpreting HbA1c data in patients with hypothyroidism.
糖化血红蛋白(HbA1c)在不同情况下会发生改变。我们推测,甲状腺状态改变可能会导致HbA1c水平变化,这可能是由于红细胞(RBC)更新率的改变所致。
本研究的目的是确定甲状腺状态改变对非糖尿病个体HbA1c水平的影响,这些个体患有明显的甲状腺功能亢进和减退症,并且如果存在这种情况,在甲状腺功能恢复正常后,HbA1c的这种变化是否会逆转。
选择患有明显甲状腺功能减退或亢进的血糖正常个体。招募年龄和性别匹配的对照组。对所有患者的基线HbA1c和网织红细胞计数(用于评估RBC更新率)进行评估并比较。此后,在一个随机选择的亚组中实现甲状腺功能稳定正常,并重新评估HbA1c和网织红细胞计数。将两组的HbA1c值和网织红细胞计数与基线进行比较。
最初选择的患者中,甲状腺功能减退组的HbA1c明显更高。甲状腺功能亢进患者的HbA1c值与对照组无显著差异。甲状腺功能减退组治疗后HbA1c降低和网织红细胞计数升高显著,血糖水平无显著变化。甲状腺功能亢进组治疗后HbA1c无显著变化。然而,网织红细胞计数显著下降。
发现甲状腺功能减退患者的基线HbA1c水平显著更高,在甲状腺功能恢复正常后显著降低,而血糖水平无任何变化。甲状腺功能亢进患者未观察到显著的基线或治疗后变化。我们的研究表明,在解释甲状腺功能减退患者的HbA1c数据时应谨慎。